Contact and place of performance
Tara Dossiema
Jamaica Plain 02130-4817
USA
NOTICE OF INTENT TO SOLE SOURCEThis notice is being published in accordance with Federal Acquisition Regulation (FAR) Subpart 5.101 requiring dissemination of information for proposed contract actions. This is a notice of intent to award a sole source contract and is not a request for competitive quotes/proposals. The statutory authority for this sole source procurement is prescribed by FAR Subpart 13.106-1(b)(1)(i)....
View moreThe Department of Veterans Affairs, Network Contract Office 01, intends to award a sole-source Blanket Purchase Agreement (BPA) to Illumina, Inc. for the procurement of specialized reagents and supplies. These items are required to operate existing Illumina laboratory equipment located in Jamaica Plain, Massachusetts. This action is being conducted under the authority of FAR Subpart 13.106-1(b)(1)(i), which allows for simplified acquisition procedures when only one source is deemed reasonably available.
The procurement is classified under NAICS 325413 for In-Vitro Diagnostic Substance Manufacturing and PSC 6550 for In Vitro Diagnostic Substances, Reagents, Test Kits and Sets. This pre-solicitation notice, published on April 30, 2024, identifies the proposed contract action as a sole-source award, and as such, no formal solicitation or Request for Quote will be issued. The government has provided one attachment containing the required justification documentation for this single-source determination.
Interested parties may submit product information and identify their interest to the primary point of contact, Tara Dossiema, via email by the response deadline of May 13, 2024. This information will be used by the government to determine whether to compete the contract, a decision which remains at the government's sole discretion. The requirement is tracked under solicitation number 36C24124Q0466.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.